In this article
For stem cell therapy in Mexico, compare the clinic's licensed activities, the cell preparation, and any research authorization separately. An establishment license and a ClinicalTrials.gov record answer different questions.[1][2][4]
Sources checked October 28, 2026. This is a document-comparison guide, not a clinic ranking, legal opinion or treatment recommendation.
What changed in Mexico's stem-cell rules in 2026?
Mexico's January 15, 2026 General Health Law reform distinguishes stem-cell banks, collection centers and regenerative-medicine establishments in Article 314. Article 316 addresses responsible sanitary personnel and committees for establishments performing specified stem-cell activities.[1]
A May 4, 2026 Diario Oficial de la Federación agreement merged several establishment procedures, including COFEPRIS-09-027, into COFEPRIS-05-034. Articles Second and Third retain separate activity categories, including stem-cell banks and collection centers, transplantation, and regenerative medicine.[2]
The May agreement specifies commencement 30 business days after publication, not on publication day. It preserves the rules applicable to applications filed before publication. An old form number therefore needs context, not an automatic conclusion that a clinic's license is invalid.[2]
These are the dated instruments reviewed here. Portal implementation and any later administrative instructions were not independently confirmed. Ask for the actual document and its scope rather than relying on a website's approval badge.
Which documents should a Mexico clinic identify?
Use the following comparison worksheet to keep different documents separate. The questions are for clarification, not a checklist that certifies a provider.
| Document or record | What to compare | Question to ask |
|---|---|---|
| Establishment license | Named facility and authorized activity category | Which activities at this address does the license cover?[2] |
| Bank or collection-center information | The distinct establishment roles defined in Article 314 | Which named establishment collects, processes or supplies the cells?[1] |
| Research authorization, where applicable | Named protocol and approving ethics/research committee | Does the document refer to the study being offered to me?[3] |
| ClinicalTrials.gov record | Sponsor-submitted study information | What is the exact NCT identifier, and where are results reported?[4] |
| Medical records and follow-up plan | Records in English and arrangements after returning home | Who supplies the records and who handles follow-up?[5] |
Does a clinical-trial listing establish authorization?
ClinicalTrials.gov says sponsors or investigators provide study information and are responsible for its accuracy and compliance. NLM reviews submissions for apparent errors, deficiencies or inconsistencies. The listing is not an individual clinic's establishment license.[4]
Mexico's separate May 4, 2026 research agreement addresses COFEPRIS-04-010 protocol authorization and specifies an approving ethics/research committee opinion among its requirements. It also removes a specified noninterventional, documentary research category from COFEPRIS authorization; compliance with applicable rules remains required. Do not turn that document into a claim that every study has the same requirements.[3]
For a paper offered as evidence, ask whether it studied the proposed cell preparation, administration route and condition. Ask for the population, comparison group, follow-up period and measured outcome. Keep a published result separate from a prediction about your own care. This page does not evaluate clinical outcomes or determine personal suitability.
What should a written quote and follow-up plan include?
The CDC's 2026 Yellow Book chapter on medical tourism says travelers should establish which services are included and where follow-up will occur. It also advises obtaining overseas medical records in English for subsequent healthcare professionals.[5]
A comparison sheet can have separate fields for the proposed procedure, cell preparation, treating clinician, facility, consultation, laboratory work, travel, lodging, follow-up and record transfer. Ask the provider to mark included, excluded or not yet determined beside each item. These are questions to resolve, not a package we promise any clinic supplies.
This guide does not publish a Mexico-wide price range or infer a discount from US directory data. A quoted amount is meaningful only with its date, currency and stated inclusions. No provider quote was independently collected for this page.
Where can you compare US clinic records?
For readers also considering a US consultation, Regenerated.com's September 2026 export contains 1,096 records listing Stem Cell Therapy among 9,042 US clinic records, across 47 states plus Washington, DC. This is directory coverage, not a count of Mexican providers, approved products or equivalent procedures.
Browse the US Stem Cell Therapy directory, or compare recorded services in Michigan Stem Cell Therapy listings and Texas Stem Cell Therapy listings.
Examples are the Alive Health and Wellness - Med Spa directory record and Texas Health Care Bone & Joint in Fort Worth. These links illustrate US directory records, not endorsements or referrals to Mexican treatment partners. Confirm current services and whether a practice accepts the consultation you are seeking.
Frequently asked questions
Is COFEPRIS-09-027 still the standalone application?
The May 4, 2026 DOF agreement expressly merges COFEPRIS-09-027 into COFEPRIS-05-034. It also preserves the rules applicable to applications filed before publication. Read the document's activity and date rather than treating the old number alone as proof of invalidity.[2]
Does an NCT number mean a clinic is government-approved?
No. ClinicalTrials.gov identifies a study record, supplied by its sponsor or investigator. The site's disclaimer says the US government does not review or approve the science of every listed study. A record is not a blanket approval of the clinic.[4]
What should I request about care after returning home?
Ask who will provide follow-up, where it will occur, what is included in the quoted amount, and who will supply medical records in English. These documentation questions reflect the CDC Yellow Book's medical-tourism guidance.[5]
Does this directory list stem-cell clinics in Tijuana?
The directory figures and links on this page concern US clinic records, not a Tijuana inventory. They offer a separate route for comparing US consultations, not evidence that a US listing offers the same cell preparation as a Mexican provider.
Sources
- Mexico DOF, January 15, 2026: General Health Law reform. Checked October 28, 2026.
- Mexico DOF, May 4, 2026: establishment-license consolidation. Checked October 28, 2026.
- Mexico DOF, May 4, 2026: research-protocol procedures. Checked October 28, 2026.
- ClinicalTrials.gov: Disclaimer, updated August 3, 2023. Checked October 28, 2026.
- CDC Yellow Book 2026: Medical tourism, April 23, 2025. Checked October 28, 2026.